Critical appraisal of case control
| Citation | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Nelwan et al. (2016) | Y | U | Y | Y | Y | U | U | Y | Y | Y |
| Total % | 100 | 0 | 100 | 100 | 100 | 0 | 0 | 100 | 100 | 100 |
| Citation | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Y | U | Y | Y | Y | U | U | Y | Y | Y | |
| Total % | 100 | 0 | 100 | 100 | 100 | 0 | 0 | 100 | 100 | 100 |
Y = yes; N = no; U = unclear. Q1: Were the groups comparable other than the presence of disease in cases or the absence of disease in controls? Q2 Were cases and controls matched appropriately? Q3: Were the same criteria used for identification of cases and controls? Q4: Was exposure measured in a standard, valid and reliable way? Q5: Was exposure measured in the same way for cases and controls? Q6: Were confounding factors identified? Q7: Were strategies to deal with confounding factors stated? Q8: Were outcomes assessed in a standard, valid and reliable way for cases and controls? Q9: Was the exposure period of interest long enough to be meaningful? Q10: Was appropriate statistical analysis used?
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.